We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Peregrine Sued By Investors Over Cancer Drug Claims

Law360, New York (October 30, 2012, 3:33 PM EDT) -- Investors hit Peregrine Pharmaceuticals Inc. with multiple securities class actions last month, alleging that the drugmaker's misleading statements about its lung cancer drug later resulted in a nosedive of the company's...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

California Central

Nature of Suit

Securities/Commodities

Judge

Subscribers Only

Date Filed

September 28, 2012


Case Title

Subscribers Only

Case Number

Subscribers Only

Court

California Central

Nature of Suit

Securities/Commodities

Judge

Subscribers Only

Date Filed

September 28, 2012


Case Title

Subscribers Only

Case Number

Subscribers Only

Court

California Central

Nature of Suit

Securities/Commodities

Judge

Subscribers Only

Date Filed

September 28, 2012

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.